Table 1 Demographics and characteristics of patients enrolled in this study.
Characteristics | Total (n = 133) | NDMM (n = 82) | RRMM (n = 51) |
|---|---|---|---|
Median age (range) | 63 (37–87) | 59 (37–79) | 66 (46–87) |
Gender | |||
Male | 78 (58.6%) | 47 (57.3%) | 33 (64.7%) |
Female | 55 (41.4%) | 35 (42.7%) | 18 (35.3%) |
Chromosomal abnormalities (%)a | |||
t (4;14) | 22 (16.5%) | 9 (10.9%) | 13 (25.4) |
t (11;14) | 19 (14.3%) | 10 (12.2%) | 9 (10.9%) |
t (14;16) | 5 (3.75%) | 3 (3.65%) | 2 (3.92%) |
del13q,del17p | 50 (37.6%) | 32 (39%) | 18 (35.3%) |
R-ISS stage | |||
I | 35 (26.3%) | 26 (31.7%) | 9 (17.6%) |
II | 47 (35.3%) | 27 (32.9%) | 20 (39.2%) |
III | 51 (38s.3%) | 19 (23.2%) | 32 (62.7%) |
Induction or maintenance regimen | |||
VD | 11 (8.3%) | 11 (13.4%) | 0 (0) |
VCD | 93 (69.9%) | 62 (75.6%) | 31 (60.8%) |
VTD | 29 (21.8%) | 9 (11%) | 20 (39.2%) |
